|
|
|
|
|
|
|
|
|
|
|
|
|
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from U.S.
Neurological 10Q and is qualified in its entirety by reference to such
financial statements.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> JUN-30-2000
<CASH> 93,000
<SECURITIES> 0
<RECEIVABLES> 573,000
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 797,000
<PP&E> 8,413,000
<DEPRECIATION> 4,672,000
<TOTAL-ASSETS> 4,637,000
<CURRENT-LIABILITIES> 1,340,000
<BONDS> 2,100,000
0
0
<COMMON> 73,000
<OTHER-SE> 1,156,000
<TOTAL-LIABILITY-AND-EQUITY> 4,637,000
<SALES> 1,271,000
<TOTAL-REVENUES> 1,271,000
<CGS> 556,000
<TOTAL-COSTS> 1,119,000
<OTHER-EXPENSES> 173,000
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 8,000
<INCOME-PRETAX> (13,000)
<INCOME-TAX> (4,000)
<INCOME-CONTINUING> (9,000)
<DISCONTINUED> 87,000
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 78,000
<EPS-BASIC> .01
<EPS-DILUTED> .01
</TABLE>
|
|